In a previous study, the investigators established the dosage of foetal glycated hemoglobin (FGH). It represents the mean of blood sugar 4-6 before the delivery. The investigators also compared the FGH of newborn of women with and without gestational diabetes mellitus (GDM) and determined that newborn of women with GDM had significantly higher FGH that newborn of women without GDM. In this study, the investigators want to compare the FGH of newborn of GDM women randomized to a group reaching the Canadian Diabetes Association recommended blood glucose objectives treatment (fasting: 5.3 mmol/L and 2-hour after meals: 6.7 mmol/L) to a group reaching lower blood glucose objectives (fasting: 4.8 mmol/L and 2-hour after meals: 5.9 mmol/L)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
5
Use diet, physical exercise of insulins to reach normal glycemic control.
Use diet, physical exercise of insulins to reach low glycemic control.
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Foetal glycated hemoglobin
Time frame: At delivery
Treatment satisfaction
Evaluated by questionnaire
Time frame: End of pregnancy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.